The Src/PLC/PKC/MEK/ERK signaling pathway is involved in aortic smooth muscle cell proliferation induced by glycated LDL

Hyun Mi Cho, Sung Hee Choi, Ki Chul Hwang, Sue Young Oh, Ho Gyung Kim, Deok Hyo Yoon, Myung Ae Choi, So Yeon Lim, Heesang Song, Yangsoo Jang, Tae Woong Kim

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Low density lipoproteins (LDL) play important roles in the pathogenesis of atherosclerosis. Diabetes is associated with accelerated atherosclerosis leading to cardiovascular disease in diabetic patients. Although LDL stimulates the proliferation of arterial smooth muscle cells (SMC), the mechanisms are not fully understood. We examined the effects of native LDL and glycated LDL on the extracellular signal-regulated kinase (ERK) pathway. Addition of native and glycated LDL to rat aorta SMCs (RASMCs) stimulated ERK phosphorylation. ERK phosphorylation was not affected by exposure to the Ca2+ chelator BAPTA-AM but inhibition of protein kinase C (PKC) with GF109203X, inhibition of Src kinase with PP1 (5 μM) and inhibition of phospholipase C (PLC) with U73122/U73343 (5 μM) all reduced ERK phosphorylation in response to glycated LDL. In addition, pretreatment of the RASMCs with a cell-permeable mitogen-activated protein kinase kinase (MEK) inhibitor (PD98059, 5 μM) markedly decreased ERK phosphorylation in response to native and glycated LDL. These findings indicate that ERK phosphorylation in response to glycated LDL involves the activation of PKC, PLC, and MEK, but is independent of intracellular Ca2+.

Original languageEnglish
Pages (from-to)60-66
Number of pages7
JournalMolecules and Cells
Volume19
Issue number1
Publication statusPublished - 2005 Dec 1

Fingerprint

Mitogen-Activated Protein Kinase Kinases
Extracellular Signal-Regulated MAP Kinases
Type C Phospholipases
LDL Lipoproteins
Protein Kinase C
Smooth Muscle Myocytes
Cell Proliferation
Phosphorylation
Aorta
Atherosclerosis
src-Family Kinases
Chelating Agents
Cardiovascular Diseases

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Cho, H. M., Choi, S. H., Hwang, K. C., Oh, S. Y., Kim, H. G., Yoon, D. H., ... Kim, T. W. (2005). The Src/PLC/PKC/MEK/ERK signaling pathway is involved in aortic smooth muscle cell proliferation induced by glycated LDL. Molecules and Cells, 19(1), 60-66.
Cho, Hyun Mi ; Choi, Sung Hee ; Hwang, Ki Chul ; Oh, Sue Young ; Kim, Ho Gyung ; Yoon, Deok Hyo ; Choi, Myung Ae ; Lim, So Yeon ; Song, Heesang ; Jang, Yangsoo ; Kim, Tae Woong. / The Src/PLC/PKC/MEK/ERK signaling pathway is involved in aortic smooth muscle cell proliferation induced by glycated LDL. In: Molecules and Cells. 2005 ; Vol. 19, No. 1. pp. 60-66.
@article{eb1eb47d1520482a81d4363f5ba46e43,
title = "The Src/PLC/PKC/MEK/ERK signaling pathway is involved in aortic smooth muscle cell proliferation induced by glycated LDL",
abstract = "Low density lipoproteins (LDL) play important roles in the pathogenesis of atherosclerosis. Diabetes is associated with accelerated atherosclerosis leading to cardiovascular disease in diabetic patients. Although LDL stimulates the proliferation of arterial smooth muscle cells (SMC), the mechanisms are not fully understood. We examined the effects of native LDL and glycated LDL on the extracellular signal-regulated kinase (ERK) pathway. Addition of native and glycated LDL to rat aorta SMCs (RASMCs) stimulated ERK phosphorylation. ERK phosphorylation was not affected by exposure to the Ca2+ chelator BAPTA-AM but inhibition of protein kinase C (PKC) with GF109203X, inhibition of Src kinase with PP1 (5 μM) and inhibition of phospholipase C (PLC) with U73122/U73343 (5 μM) all reduced ERK phosphorylation in response to glycated LDL. In addition, pretreatment of the RASMCs with a cell-permeable mitogen-activated protein kinase kinase (MEK) inhibitor (PD98059, 5 μM) markedly decreased ERK phosphorylation in response to native and glycated LDL. These findings indicate that ERK phosphorylation in response to glycated LDL involves the activation of PKC, PLC, and MEK, but is independent of intracellular Ca2+.",
author = "Cho, {Hyun Mi} and Choi, {Sung Hee} and Hwang, {Ki Chul} and Oh, {Sue Young} and Kim, {Ho Gyung} and Yoon, {Deok Hyo} and Choi, {Myung Ae} and Lim, {So Yeon} and Heesang Song and Yangsoo Jang and Kim, {Tae Woong}",
year = "2005",
month = "12",
day = "1",
language = "English",
volume = "19",
pages = "60--66",
journal = "Molecules and Cells",
issn = "1016-8478",
publisher = "Korean Society for Molecular and Cellular Biology",
number = "1",

}

Cho, HM, Choi, SH, Hwang, KC, Oh, SY, Kim, HG, Yoon, DH, Choi, MA, Lim, SY, Song, H, Jang, Y & Kim, TW 2005, 'The Src/PLC/PKC/MEK/ERK signaling pathway is involved in aortic smooth muscle cell proliferation induced by glycated LDL', Molecules and Cells, vol. 19, no. 1, pp. 60-66.

The Src/PLC/PKC/MEK/ERK signaling pathway is involved in aortic smooth muscle cell proliferation induced by glycated LDL. / Cho, Hyun Mi; Choi, Sung Hee; Hwang, Ki Chul; Oh, Sue Young; Kim, Ho Gyung; Yoon, Deok Hyo; Choi, Myung Ae; Lim, So Yeon; Song, Heesang; Jang, Yangsoo; Kim, Tae Woong.

In: Molecules and Cells, Vol. 19, No. 1, 01.12.2005, p. 60-66.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The Src/PLC/PKC/MEK/ERK signaling pathway is involved in aortic smooth muscle cell proliferation induced by glycated LDL

AU - Cho, Hyun Mi

AU - Choi, Sung Hee

AU - Hwang, Ki Chul

AU - Oh, Sue Young

AU - Kim, Ho Gyung

AU - Yoon, Deok Hyo

AU - Choi, Myung Ae

AU - Lim, So Yeon

AU - Song, Heesang

AU - Jang, Yangsoo

AU - Kim, Tae Woong

PY - 2005/12/1

Y1 - 2005/12/1

N2 - Low density lipoproteins (LDL) play important roles in the pathogenesis of atherosclerosis. Diabetes is associated with accelerated atherosclerosis leading to cardiovascular disease in diabetic patients. Although LDL stimulates the proliferation of arterial smooth muscle cells (SMC), the mechanisms are not fully understood. We examined the effects of native LDL and glycated LDL on the extracellular signal-regulated kinase (ERK) pathway. Addition of native and glycated LDL to rat aorta SMCs (RASMCs) stimulated ERK phosphorylation. ERK phosphorylation was not affected by exposure to the Ca2+ chelator BAPTA-AM but inhibition of protein kinase C (PKC) with GF109203X, inhibition of Src kinase with PP1 (5 μM) and inhibition of phospholipase C (PLC) with U73122/U73343 (5 μM) all reduced ERK phosphorylation in response to glycated LDL. In addition, pretreatment of the RASMCs with a cell-permeable mitogen-activated protein kinase kinase (MEK) inhibitor (PD98059, 5 μM) markedly decreased ERK phosphorylation in response to native and glycated LDL. These findings indicate that ERK phosphorylation in response to glycated LDL involves the activation of PKC, PLC, and MEK, but is independent of intracellular Ca2+.

AB - Low density lipoproteins (LDL) play important roles in the pathogenesis of atherosclerosis. Diabetes is associated with accelerated atherosclerosis leading to cardiovascular disease in diabetic patients. Although LDL stimulates the proliferation of arterial smooth muscle cells (SMC), the mechanisms are not fully understood. We examined the effects of native LDL and glycated LDL on the extracellular signal-regulated kinase (ERK) pathway. Addition of native and glycated LDL to rat aorta SMCs (RASMCs) stimulated ERK phosphorylation. ERK phosphorylation was not affected by exposure to the Ca2+ chelator BAPTA-AM but inhibition of protein kinase C (PKC) with GF109203X, inhibition of Src kinase with PP1 (5 μM) and inhibition of phospholipase C (PLC) with U73122/U73343 (5 μM) all reduced ERK phosphorylation in response to glycated LDL. In addition, pretreatment of the RASMCs with a cell-permeable mitogen-activated protein kinase kinase (MEK) inhibitor (PD98059, 5 μM) markedly decreased ERK phosphorylation in response to native and glycated LDL. These findings indicate that ERK phosphorylation in response to glycated LDL involves the activation of PKC, PLC, and MEK, but is independent of intracellular Ca2+.

UR - http://www.scopus.com/inward/record.url?scp=22844436841&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22844436841&partnerID=8YFLogxK

M3 - Article

C2 - 15750341

AN - SCOPUS:22844436841

VL - 19

SP - 60

EP - 66

JO - Molecules and Cells

JF - Molecules and Cells

SN - 1016-8478

IS - 1

ER -